For decades, the dominant model of mental health treatment has focused almost exclusively on neurotransmitters. A growing body of research suggests we have been missing a crucial dimension: the metabolic health of the brain itself.
The Neurotransmitter Model and Its Limits
For decades, the dominant model of mental health treatment has focused almost exclusively on neurotransmitters — the chemical messengers that carry signals between brain cells. The success of SSRIs and other pharmacological interventions seemed to validate this approach. But a growing body of research suggests we have been missing a crucial dimension: the metabolic health of the brain itself.
Metabolic psychiatry is an emerging field that examines the relationship between the brain's energy production systems and mental health. The central hypothesis is straightforward: the brain is an extraordinarily energy-hungry organ, consuming roughly 20% of the body's total energy despite comprising only 2% of its mass. When the systems that produce and regulate that energy are disrupted — through mitochondrial dysfunction, insulin resistance, oxidative stress, or inflammation — the consequences for mental health can be profound.
What the Research Is Showing
The evidence base for metabolic psychiatry is growing rapidly. Studies have demonstrated associations between mitochondrial dysfunction and conditions including depression, bipolar disorder, schizophrenia, and anxiety disorders. Research into the ketogenic diet — originally developed as a treatment for epilepsy — has shown promising results in treatment-resistant depression and bipolar disorder, with several clinical trials now underway.
Insulin resistance, increasingly prevalent in the general population, has been linked to cognitive impairment, depression, and elevated risk of dementia. The gut-brain axis — the bidirectional communication pathway between the gastrointestinal microbiome and the central nervous system — is now understood to play a significant role in mood regulation, with implications for dietary and probiotic interventions.
What This Means for Clinical Practice
At Cardinal Clinic, we have always taken a holistic view of mental health — one that considers the whole person, not just their symptoms. The emerging evidence from metabolic psychiatry reinforces this approach and opens new avenues for treatment, particularly for patients who have not responded adequately to conventional pharmacological or psychological interventions.
This does not mean abandoning established treatments. SSRIs, mood stabilisers, antipsychotics, and evidence-based psychotherapies remain the cornerstone of mental health care. But integrating metabolic assessment — including markers of inflammation, mitochondrial function, and metabolic health — into the diagnostic process may help identify additional treatment targets and improve outcomes for a significant proportion of patients.
The field is young, and the evidence base is still developing. But the direction of travel is clear: the future of psychiatry is likely to be more integrative, more personalised, and more attentive to the body as a whole.